chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Discomfort, Fatigue, Pain
Clinical narrative: Shaking; chills; extreme fatigue; Fever; loss appetite; Discomfort at ulceration; Had excruciating pain; resetless; patient reports developing a lipschutz ulcer/ Developed a lipschutz ulcer, (internal vulvar ulcer) one large one and one small one/ Dark red ulcer at beginning, like a scab/ Ulcer worsened, larger and deeper; This spontaneous case was reported by a patient and describes the occurrence of DECREASED APPETITE (loss appetite), DISCOMFORT (Discomfort at ulceration), PAIN (Had excruciating pain), RESTLESSNESS (resetless) and VULVAL ULCERATION (patient reports developing a lipschutz ulcer/ Developed a lipschutz ulcer, (internal vulvar ulcer) one large one and one small one/ Dark red ulcer at beginning, like a scab/ Ulcer worsened, larger and deeper) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and METOPROLOL for an unknown indication.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (loss appetite), DISCOMFORT (Discomfort at ulceration), PAIN (Had excruciating pain), RESTLESSNESS (resetless), VULVAL ULCERATION (patient reports developing a lipschutz ulcer/ Developed a lipschutz ulcer, (internal vulvar ulcer) one large one and one small one/ Dark red ulcer at beginning, like a scab/ Ulcer worsened, larger and deeper), TREMOR (Shaking), CHILLS (chills), FATIGUE (extreme fatigue) and PYREXIA (Fever). The patient was treated with LIDOCAINE for Adverse event, at an unspecified dose and frequency and TRIAMCINOLONE for Adverse event, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (loss appetite), DISCOMFORT (Discomfort at ulceration), PAIN (Had excruciating pain), RESTLESSNESS (resetless), VULVAL ULCERATION (patient reports developing a lipschutz ulcer/ Developed a lipschutz ulcer, (internal vulvar ulcer) one large one and one small one/ Dark red ulcer at beginning, like a scab/ Ulcer worsened, larger and deeper), TREMOR (Shaking), CHILLS (chills), FATIGUE (extreme fatigue) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Sexually transmitted disease test: negative (Negative) STD tests negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications also included iron supplement.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Restlessness, Sexually transmitted disease test, Tremor, Vulval ulceration
Clinical narrative: Shaking; chills; extreme fatigue; Fever; loss appetite; Discomfort at ulceration; Had excruciating pain; resetless; patient reports developing a lipschutz ulcer/ Developed a lipschutz ulcer, (internal vulvar ulcer) one large one and one small one/ Dark red ulcer at beginning, like a scab/ Ulcer worsened, larger and deeper; This spontaneous case was reported by a patient and describes the occurrence of DECREASED APPETITE (loss appetite), DISCOMFORT (Discomfort at ulceration), PAIN (Had excruciating pain), RESTLESSNESS (resetless) and VULVAL ULCERATION (patient reports developing a lipschutz ulcer/ Developed a lipschutz ulcer, (internal vulvar ulcer) one large one and one small one/ Dark red ulcer at beginning, like a scab/ Ulcer worsened, larger and deeper) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and METOPROLOL for an unknown indication.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (loss appetite), DISCOMFORT (Discomfort at ulceration), PAIN (Had excruciating pain), RESTLESSNESS (resetless), VULVAL ULCERATION (patient reports developing a lipschutz ulcer/ Developed a lipschutz ulcer, (internal vulvar ulcer) one large one and one small one/ Dark red ulcer at beginning, like a scab/ Ulcer worsened, larger and deeper), TREMOR (Shaking), CHILLS (chills), FATIGUE (extreme fatigue) and PYREXIA (Fever). The patient was treated with LIDOCAINE for Adverse event, at an unspecified dose and frequency and TRIAMCINOLONE for Adverse event, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (loss appetite), DISCOMFORT (Discomfort at ulceration), PAIN (Had excruciating pain), RESTLESSNESS (resetless), VULVAL ULCERATION (patient reports developing a lipschutz ulcer/ Developed a lipschutz ulcer, (internal vulvar ulcer) one large one and one small one/ Dark red ulcer at beginning, like a scab/ Ulcer worsened, larger and deeper), TREMOR (Shaking), CHILLS (chills), FATIGUE (extreme fatigue) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Sexually transmitted disease test: negative (Negative) STD tests negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications also included iron supplement.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Gene mutation identification test, Maternal exposure during pregnancy, Pregnancy test, SARS-CoV-2 test
Clinical narrative: Expired vaccine given; pregnant patient administered expired booster shot; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine given) and MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient administered expired booster shot) in a 23-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A, 002C21A and 033C21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: TDAP (Manufacturer: Boostrix, Lot number : J3946, Route: IM deltoid left and dose number 1.) on 16-Nov-2021. Concurrent medical conditions included Allergy to antibiotic, Allergy to antibiotic and Allergy to antibiotic.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Nov-2021 at 10:40 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 10-Feb-2022. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine given) and MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient administered expired booster shot). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine given) had resolved. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient administered expired booster shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jul-2021, Pregnancy test: positive (Positive) positive. On 16-Jul-2021, Ultrasound scan: no abnormal findings no abnormal findings. On 23-Jul-2021, Ultrasound scan: no abnormal findings no abnormal findings. On 04-Dec-2021, SARS-CoV-2 test: positive (Positive) positive. On an unknown date, Gene mutation identification test: no abnormal findings no abnormal findings.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 08-Dec-2021: Follow-up received on 08-DEC-2021, contains significant information includes: reporter details,patient height, weight, race, pregnancy information, medical history, laboratory details and product dose details were added.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan
Clinical narrative: Expired vaccine given; pregnant patient administered expired booster shot; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine given) and MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient administered expired booster shot) in a 23-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A, 002C21A and 033C21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: TDAP (Manufacturer: Boostrix, Lot number : J3946, Route: IM deltoid left and dose number 1.) on 16-Nov-2021. Concurrent medical conditions included Allergy to antibiotic, Allergy to antibiotic and Allergy to antibiotic.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Nov-2021 at 10:40 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 10-Feb-2022. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine given) and MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient administered expired booster shot). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine given) had resolved. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient administered expired booster shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jul-2021, Pregnancy test: positive (Positive) positive. On 16-Jul-2021, Ultrasound scan: no abnormal findings no abnormal findings. On 23-Jul-2021, Ultrasound scan: no abnormal findings no abnormal findings. On 04-Dec-2021, SARS-CoV-2 test: positive (Positive) positive. On an unknown date, Gene mutation identification test: no abnormal findings no abnormal findings.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 08-Dec-2021: Follow-up received on 08-DEC-2021, contains significant information includes: reporter details,patient height, weight, race, pregnancy information, medical history, laboratory details and product dose details were added.
Age: 40.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 40-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Aug-2021 at 9:28 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 26-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 26-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-405465, MOD-2021-405476, MOD-2021-405484, MOD-2021-405489, MOD-2021-405498, MOD-2021-405503, MOD-2021-405517, MOD-2021-405535, MOD-2021-405538, MOD-2021-405541, MOD-2021-405544, MOD-2021-405545, MOD-2021-405550, MOD-2021-405551, MOD-2021-405568, MOD-2021-405575, MOD-2021-405579, MOD-2021-405585, MOD-2021-405588, MOD-2021-405590, MOD-2021-405600, MOD-2021-405608, MOD-2021-405611, MOD-2021-405613, MOD-2021-405622, MOD-2021-405633, MOD-2021-405636, MOD-2021-405642, MOD-2021-405645, MOD-2021-405652, MOD-2021-405653, MOD-2021-405656, MOD-2021-405659, MOD-2021-405660, MOD-2021-405661, MOD-2021-405675, MOD-2021-405676, MOD-2021-405678, MOD-2021-405682, MOD-2021-405685, MOD-2021-405691, MOD-2021-405695, MOD-2021-405696, MOD-2021-405699, MOD-2021-405701, MOD-2021-405702, MOD-2021-405705, MOD-2021-405711, MOD-2021-405721, MOD-2021-405723, MOD-2021-405735, MOD-2021-405738, MOD-2021-405740, MOD-2021-405743, MOD-2021-405749, MOD-2021-405751, MOD-2021-405756, MOD-2021-405758, MOD-2021-405760, MOD-2021-405761, MOD-2021-405766, MOD-2021-405770, MOD-2021-405775, MOD-2021-405780, MOD-2021-405785, MOD-2021-405789, MOD-2021-405790, MOD-2021-405793, MOD-2021-405797, MOD-2021-405804, MOD-2021-405810, MOD-2021-405837, MOD-2021-405840, MOD-2021-405843, MOD-2021-405846, MOD-2021-405847, MOD-2021-405851, MOD-2021-405852, MOD-2021-405854, MOD-2021-405855, MOD-2021-405856, MOD-2021-405858, MOD-2021-405860, MOD-2021-405862, MOD-2021-405864, MOD-2021-405865, MOD-2021-405867, MOD-2021-405868, MOD-2021-405869, MOD-2021-405874, MOD-2021-405875, MOD-2021-405877, MOD-2021-405880, MOD-2021-405881, MOD-2021-405882, MOD-2021-405896, MOD-2021-405897, MOD-2021-405898, MOD-2021-405899, MOD-2021-405900, MOD-2021-405901, MOD-2021-405903, MOD-2021-405904 (Patient Link).
Age: 46.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021 at 4:35 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 09-Sep-2021 at 4:35 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 09-Sep-2021 at 4:35 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   This case was linked to MOD-2021-405465, MOD-2021-405476, MOD-2021-405484, MOD-2021-405489, MOD-2021-405498, MOD-2021-405503, MOD-2021-405517, MOD-2021-405535, MOD-2021-405538, MOD-2021-405541, MOD-2021-405544, MOD-2021-405545, MOD-2021-405550, MOD-2021-405551, MOD-2021-405568, MOD-2021-405575, MOD-2021-405579, MOD-2021-405585, MOD-2021-405588, MOD-2021-405590, MOD-2021-405600, MOD-2021-405608, MOD-2021-405611, MOD-2021-405613, MOD-2021-405622, MOD-2021-405633, MOD-2021-405636, MOD-2021-405642, MOD-2021-405645, MOD-2021-405652, MOD-2021-405653, MOD-2021-405656, MOD-2021-405659, MOD-2021-405660, MOD-2021-405661, MOD-2021-405675, MOD-2021-405676, MOD-2021-405678, MOD-2021-405682, MOD-2021-405685, MOD-2021-405691, MOD-2021-405695, MOD-2021-405696, MOD-2021-405699, MOD-2021-405701, MOD-2021-405702, MOD-2021-405705, MOD-2021-405711, MOD-2021-405721, MOD-2021-405723, MOD-2021-405735, MOD-2021-405738, MOD-2021-405740, MOD-2021-405743, MOD-2021-405749, MOD-2021-405751, MOD-2021-405756, MOD-2021-405758, MOD-2021-405760, MOD-2021-405761, MOD-2021-405766, MOD-2021-405770, MOD-2021-405775, MOD-2021-405780, MOD-2021-405785, MOD-2021-405789, MOD-2021-405793, MOD-2021-405790, MOD-2021-405797, MOD-2021-405804, MOD-2021-405810, MOD-2021-405837, MOD-2021-405840, MOD-2021-405843, MOD-2021-405846, MOD-2021-405847, MOD-2021-405851, MOD-2021-405852, MOD-2021-405854, MOD-2021-405855, MOD-2021-405856, MOD-2021-405858, MOD-2021-405860, MOD-2021-405862, MOD-2021-405864, MOD-2021-405865, MOD-2021-405867, MOD-2021-405868, MOD-2021-405869, MOD-2021-405874, MOD-2021-405875, MOD-2021-405877, MOD-2021-405880, MOD-2021-405881, MOD-2021-405882, MOD-2021-405896, MOD-2021-405897, MOD-2021-405898, MOD-2021-405899, MOD-2021-405900, MOD-2021-405901, MOD-2021-405903, MOD-2021-405904 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 19-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 19-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea
Clinical narrative: large lump in left armpit; chills; fever; runny nose; sore throat; body ache; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), VACCINATION SITE MASS (large lump in left armpit) and CHILLS (chills) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 065FZ1A or 065FZIA, 003B21A and 041BZ1A or 041BZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Dec-2021, the patient experienced RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), CHILLS (chills) and PYREXIA (fever). On 06-Dec-2021, the patient experienced VACCINATION SITE MASS (large lump in left armpit). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), CHILLS (chills) and PYREXIA (fever) had resolved and VACCINATION SITE MASS (large lump in left armpit) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: large lump in left armpit; chills; fever; runny nose; sore throat; body ache; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), VACCINATION SITE MASS (large lump in left armpit) and CHILLS (chills) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 065FZ1A or 065FZIA, 003B21A and 041BZ1A or 041BZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Dec-2021, the patient experienced RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), CHILLS (chills) and PYREXIA (fever). On 06-Dec-2021, the patient experienced VACCINATION SITE MASS (large lump in left armpit). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), CHILLS (chills) and PYREXIA (fever) had resolved and VACCINATION SITE MASS (large lump in left armpit) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Given 0.25ml dose as a first dose; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Given 0.25ml dose as a first dose) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053E21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 ml. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Given 0.25ml dose as a first dose). At the time of the report, ACCIDENTAL UNDERDOSE (Given 0.25ml dose as a first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter. No treatment was reported by the reporter.   This case was linked to MOD-2021-406059 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pruritus, Rash, Skin warm, Urticaria
Clinical narrative: States she has patches of hives and rashes at areas lymph nodes especially behind ears it is hot and itchy; States she has patches of hives and rashes at areas lymph nodes especially behind ears it is hot and itchy; has patches of hives and rashes at areas lymph nodes; Reports 9 days after booster dose this past Sunday afternoon/ night she was aching all over body; states she broke out in itchy hives on Saturday/ has patches of hives and rashes at areas lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of SKIN WARM (States she has patches of hives and rashes at areas lymph nodes especially behind ears it is hot and itchy), PRURITUS (States she has patches of hives and rashes at areas lymph nodes especially behind ears it is hot and itchy), URTICARIA (states she broke out in itchy hives on Saturday/ has patches of hives and rashes at areas lymph nodes), RASH (has patches of hives and rashes at areas lymph nodes) and MYALGIA (Reports 9 days after booster dose this past Sunday afternoon/ night she was aching all over body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 06BF21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Dec-2021, the patient experienced URTICARIA (states she broke out in itchy hives on Saturday/ has patches of hives and rashes at areas lymph nodes). On 05-Dec-2021, the patient experienced MYALGIA (Reports 9 days after booster dose this past Sunday afternoon/ night she was aching all over body). On an unknown date, the patient experienced SKIN WARM (States she has patches of hives and rashes at areas lymph nodes especially behind ears it is hot and itchy), PRURITUS (States she has patches of hives and rashes at areas lymph nodes especially behind ears it is hot and itchy) and RASH (has patches of hives and rashes at areas lymph nodes). At the time of the report, SKIN WARM (States she has patches of hives and rashes at areas lymph nodes especially behind ears it is hot and itchy), PRURITUS (States she has patches of hives and rashes at areas lymph nodes especially behind ears it is hot and itchy), URTICARIA (states she broke out in itchy hives on Saturday/ has patches of hives and rashes at areas lymph nodes), RASH (has patches of hives and rashes at areas lymph nodes) and MYALGIA (Reports 9 days after booster dose this past Sunday afternoon/ night she was aching all over body) outcome was unknown.            Concomitant medications were not provided. Treatment information was not provided.
Age: 28.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and MYALGIA (Body aches) in a 29-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included VITAMIN B COMPLEX, BIOTIN and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills) and MYALGIA (Body aches). At the time of the report, CHILLS (Chills) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-406040, MOD-2021-406041 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Dec-2021, the patient experienced MYALGIA (body aches). At the time of the report, MYALGIA (body aches) outcome was unknown.            Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received the booster too soon; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the booster too soon) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 ml. On 04-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the booster too soon). On 04-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the booster too soon) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-406059 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: ringing on his ear; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing on his ear) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TINNITUS (ringing on his ear). At the time of the report, TINNITUS (ringing on his ear) outcome was unknown.            No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site pain
Clinical narrative: General reaction; Local injection pain; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (General reaction) and VACCINATION SITE PAIN (Local injection pain) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2020, the patient experienced VACCINATION COMPLICATION (General reaction) and VACCINATION SITE PAIN (Local injection pain). In December 2020, VACCINATION COMPLICATION (General reaction) and VACCINATION SITE PAIN (Local injection pain) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient post receiving their first dose experienced local injection pain and general reaction that lasted for a day or so.  No Concomitant product use was reported. No treatment information was provided.   This case was linked to MOD-2021-406049, MOD-2021-406057 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: she had severe hives throughout her body; This spontaneous case was reported by an other health care professional and describes the occurrence of URTICARIA (she had severe hives throughout her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced URTICARIA (she had severe hives throughout her body). The patient was treated with METHYLPREDNISOLONE (MEDROL DOSEPAK) for Hives, at a dose of UNK dosage form and PREDNISONE for Hives, at a dose of 40 mg. At the time of the report, URTICARIA (she had severe hives throughout her body) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Blood cholesterol abnormal, Product administration interrupted
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of BLOOD CHOLESTEROL ABNORMAL (Cholesterol dysfunction) and PRODUCT ADMINISTRATION INTERRUPTED (more than 42 days passed for administration of second dose) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042C21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression. Concomitant products included BUPROPION for Depression.    On 18-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced BLOOD CHOLESTEROL ABNORMAL (Cholesterol dysfunction). On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (more than 42 days passed for administration of second dose). At the time of the report, BLOOD CHOLESTEROL ABNORMAL (Cholesterol dysfunction) had not resolved and PRODUCT ADMINISTRATION INTERRUPTED (more than 42 days passed for administration of second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient reported that after the first Moderna dose they developed cholesterol dysfunction and stated that the start date was hard to tell but at least 3 days unnoticed. The patient went to the doctor in the first part of November and the doctor gave them an exemption for the second dose and this continued. Reportedly, the patient didn't receive the second dose.  No treatment information was provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: More reaction than the first dose; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (More reaction than the first dose) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (More reaction than the first dose). At the time of the report, VACCINATION COMPLICATION (More reaction than the first dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication provided.   This case was linked to MOD-2021-406038, MOD-2021-406057 (Patient Link).
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: second fatigue; first fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (first fatigue) and FATIGUE (second fatigue) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Nov-2021, the patient experienced FATIGUE (first fatigue). On 03-Dec-2021, the patient experienced FATIGUE (second fatigue). On 26-Nov-2021, FATIGUE (first fatigue) had resolved. On 07-Dec-2021, FATIGUE (second fatigue) had resolved.            No concomitant medication reported. No treatment information was provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain in the arm/Not a severe reaction; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (Pain in the arm/Not a severe reaction) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain in the arm/Not a severe reaction). At the time of the report, VACCINATION SITE PAIN (Pain in the arm/Not a severe reaction) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Treatment medication were not reported.   This case was linked to MOD-2021-406038, MOD-2021-406049 (Patient Link).
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tired after their second  dose; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (tired after their second  dose) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A, 002B and 033F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (tired after their second  dose). At the time of the report, FATIGUE (tired after their second  dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.     No treatment medications were reported.   This case was linked to MOD-2021-406076 (Patient Link).
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tired after their booster dose; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (Tired after their booster dose) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033F21A, 007M20A and 002B) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Tired after their booster dose). At the time of the report, FATIGUE (Tired after their booster dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter. No treatment was reported by the reporter.   This case was linked to MOD-2021-406064 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (I'm worried that the vaccine was out of refrigerator when administered) and PRODUCT STORAGE ERROR (doses were out in the open and not in a refrigerator) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (I'm worried that the vaccine was out of refrigerator when administered) and PRODUCT STORAGE ERROR (doses were out in the open and not in a refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (I'm worried that the vaccine was out of refrigerator when administered) and PRODUCT STORAGE ERROR (doses were out in the open and not in a refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster dose given too soon/The patient had received the Pfizer vaccine as the primary series.; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose given too soon/The patient had received the Pfizer vaccine as the primary series.) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (First dose) on 20-May-2021 and Pfizer (Second dose) on 10-Jul-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose given too soon/The patient had received the Pfizer vaccine as the primary series.). On 30-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose given too soon/The patient had received the Pfizer vaccine as the primary series.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was given the booster dose too soon. The patient had received the Pfizer vaccine as the primary series.  No Concomitant product use was reported. No treatment information was provided.   This case was linked to MOD-2021-406059 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Gait disturbance, Headache
Clinical narrative: can't walk; nerve pain on her foot that seems to be getting worst; patient can't wear shoes; arm hurt/foot ankle pain slowly; feeling slightly dizzy; nervous; foot ankle pain slowly going to her leg; tiredness; headaches; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (can't walk), NEURALGIA (nerve pain on her foot that seems to be getting worst), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (patient can't wear shoes), PAIN IN EXTREMITY (arm hurt/foot ankle pain slowly) and DIZZINESS (feeling slightly dizzy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 06-Dec-2021 at 9:22 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, the patient experienced GAIT DISTURBANCE (can't walk), NEURALGIA (nerve pain on her foot that seems to be getting worst), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (patient can't wear shoes), PAIN IN EXTREMITY (arm hurt/foot ankle pain slowly), DIZZINESS (feeling slightly dizzy), NERVOUSNESS (nervous), ARTHRALGIA (foot ankle pain slowly going to her leg), FATIGUE (tiredness) and HEADACHE (headaches). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (can't walk), NEURALGIA (nerve pain on her foot that seems to be getting worst), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (patient can't wear shoes), PAIN IN EXTREMITY (arm hurt/foot ankle pain slowly), DIZZINESS (feeling slightly dizzy), NERVOUSNESS (nervous), ARTHRALGIA (foot ankle pain slowly going to her leg), FATIGUE (tiredness) and HEADACHE (headaches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  The patient stated that the nerve pain on her foot seemed to be getting worst. She was nervous and concerned about her symptoms. The patient mentioned that she was on her mid 40s and was a fairly healthy person and a vegetarian.
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Nervousness, Neuralgia, Pain in extremity
Clinical narrative: can't walk; nerve pain on her foot that seems to be getting worst; patient can't wear shoes; arm hurt/foot ankle pain slowly; feeling slightly dizzy; nervous; foot ankle pain slowly going to her leg; tiredness; headaches; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (can't walk), NEURALGIA (nerve pain on her foot that seems to be getting worst), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (patient can't wear shoes), PAIN IN EXTREMITY (arm hurt/foot ankle pain slowly) and DIZZINESS (feeling slightly dizzy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 06-Dec-2021 at 9:22 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, the patient experienced GAIT DISTURBANCE (can't walk), NEURALGIA (nerve pain on her foot that seems to be getting worst), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (patient can't wear shoes), PAIN IN EXTREMITY (arm hurt/foot ankle pain slowly), DIZZINESS (feeling slightly dizzy), NERVOUSNESS (nervous), ARTHRALGIA (foot ankle pain slowly going to her leg), FATIGUE (tiredness) and HEADACHE (headaches). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (can't walk), NEURALGIA (nerve pain on her foot that seems to be getting worst), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (patient can't wear shoes), PAIN IN EXTREMITY (arm hurt/foot ankle pain slowly), DIZZINESS (feeling slightly dizzy), NERVOUSNESS (nervous), ARTHRALGIA (foot ankle pain slowly going to her leg), FATIGUE (tiredness) and HEADACHE (headaches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  The patient stated that the nerve pain on her foot seemed to be getting worst. She was nervous and concerned about her symptoms. The patient mentioned that she was on her mid 40s and was a fairly healthy person and a vegetarian.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: felt chest pain after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (felt chest pain after the vaccine) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 0441321A or 0441B21A) for COVID-19 vaccination.     The patient's past medical history included Sickness (patient may had COVID-19, was very sick at that time. Not confirmed as COVID-19.) in February 2020.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (felt chest pain after the vaccine). At the time of the report, CHEST PAIN (felt chest pain after the vaccine) had resolved.            No concomitant medication reported. No treatment information provided.  Patient may had Covid-19 in February 2020 and was very sick at that time. Patient was not diagnosed as Covid-19   This case was linked to MOD-2021-406236 (Patient Link).